RecruitingPhase 4NCT06121466

Effect of Abdominal Wall Injections on Abdominal Pain

Sponsor

Oregon Health and Science University

Enrollment

45 participants

Start Date

Jan 1, 2023

Study Type

INTERVENTIONAL

Conditions

Anterior Cutaneous Nerve Entrapment Syndrome

Summary

This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Abdominal wall injections with lidocaine 2% for people with anterior cutaneous nerve entrapment syndrome. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAbdominal wall injections with lidocaine 2%

Injections will be administered for patient who are identified as having abdominal wall pain.

Locations(2)

OHSU

Portland, Oregon, United States

Oregon Health Sciences University

Portland, Oregon, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06121466